The future of medicine is personal. But for too many of us, it’s a future built on incomplete information.
At GeneVault™, we are a genomics intelligence company focused on Real-World Health Data with a core emphasis on genomics. By unlocking access to ethically sourced real-world datasets and integrating genomic, phenomic, and clinical outcomes, we're building a more complete picture of human health—paving the way for precision medicine that works for everyone.
Discover the Gap Partner With UsFor decades, a hidden crisis has grown at the heart of medical research: limited and non-representative real-world health data—especially genomic data—has created a profound Data Intelligence Gap. This isn't just a challenge of representation; it's a blind spot in the data that drives decisions across drug development and clinical care.
When real-world datasets and genomic studies are based on a narrow slice of humanity, new drugs and treatments may not work as intended—or may cause unexpected side effects—for underrepresented populations.
Unique genomic insights from diverse populations that could unlock cures or new disease understandings remain hidden, slowing progress for everyone.
This imbalance in real-world health data means the promise of precision medicine may leave many behind, deepening existing disparities across communities.
Accessing and using diverse real-world genomic and clinical data responsibly is complex. Here are the main challenges:
Valuable real-world genomic and clinical information often sits in separate databases worldwide—like unconnected islands—making it hard to access and combine for meaningful research.
Genomic and patient data is highly sensitive. Sharing it requires extreme security and navigating diverse privacy laws across countries (like GDPR or HIPAA).
Data Custodians—hospitals, research institutes, and biobanks—need absolute assurance that their real-world data will be used ethically and that they will remain in control.
The technology to securely analyze distributed real-world data (federation) without moving it has been a major hurdle — until now.
GeneVault™ provides a platform built on security and ethics that brings research to real-world data. We enable researchers to analyze genomic and health datasets in place—preserving sovereignty while unlocking insights that advance precision medicine.
Our technology allows analysis of data without it ever leaving its secure, local environment. Researchers send questions to the data, and only aggregated, anonymous results are returned.
We combine genomic (the blueprint), phenomic (the expression), and Real-World Data (the outcomes) to create a rich, multi-dimensional view of health.
Our platform is built to meet the highest ethical standards and comply with international privacy laws, ensuring data custodians always stay in control and patients are always protected.
GeneVault™ enables secure, federated access to ethically sourced genomic and real-world datasets. While our platform supports research across many therapeutic areas, we prioritise domains where representative data and federated analytics can create the greatest impact.
Enabling oncology researchers to securely access and analyse diverse genomic and real-world datasets in place. Our platform supports studies in biomarker discovery, tumour heterogeneity, and population-specific treatment response.
Supporting immune-focused research by providing controlled access to ancestry-rich genomic and phenotypic datasets. GeneVault enables federated exploration of immune variation and disease susceptibility.
Empowering studies that connect maternal–fetal genomics with longitudinal clinical outcomes. GeneVault enables responsible, privacy-preserving access to reproductive and perinatal health datasets.
Facilitating federated analysis of metagenomic and clinical datasets so researchers can explore microbiome–host interactions while data remains securely governed at its source.
Providing a scalable, compliant framework for cardiometabolic, neurological, rare disease, and other precision medicine studies that depend on secure access to representative datasets.
GeneVault™ serves as secure, federated infrastructure for data-driven discovery. By enabling access to diverse datasets under full custodian control, we empower researchers and partners to generate deeper, more representative insights across precision medicine.
A global biopharmaceutical company aims to deepen its understanding of population-specific tumour biology in East Africa—a region critically underrepresented in genomic and real-world oncology datasets. Improving diversity in tumour genomics from East African populations is essential for developing more inclusive biomarkers and strengthening global precision oncology efforts.
Outcome: The biopharma team gains ethically sourced, population-representative insights into tumour genomics from one of the most underrepresented regions globally. East African Data Custodians maintain full sovereignty while contributing to global oncology innovation—ultimately advancing more equitable precision oncology therapies.
To accelerate the future of precision medicine by closing the Data Intelligence Gap and unlocking more complete, equitable real-world insights—especially those driven by genomics.
A world where every person, regardless of background, benefits from precision medicine informed by representative real-world and genomic data. A world without blind spots.
Building a global ecosystem founded on collaboration, recognized expertise, and unwavering commitment to standards.

Finalists for Cohort 6 of Tech4Trust by TrustValley, underscoring our dedication to trustworthy technology in genomic data.
TrustValley Tech4Trust Finalist
Swiss Biotech Day Pitch Winner 2025





Seasoned leaders guiding GeneVault™'s mission to close the Data Intelligence Gap with real-world health and genomic data.
Chief Executive Officer
Pioneer in personalized health, driving GeneVault™'s mission for inclusive and equitable precision medicine.
Chief Commercial Officer
Leading growth and data commercialization strategies to expand GeneVault™'s impact in healthcare innovation.
Chief Technology Officer
Driving the technological foundation of GeneVault™ with deep expertise in bioinformatics and system architecture.
Chief Financial Officer
Steering GeneVault™'s financial strategy with decades of experience in governance and sustainable growth.
We'd love to hear from you. Whether you're interested in partnership, research collaboration, or learning more about GeneVault™ and our real-world genomics work, please reach out.
Email: contact@genevault.com
Follow us: LinkedIn
For partnership inquiries, collaborations, vendor requests, or media, please use the contact form or email us directly.